MedPath

Formulation and manufacturing of corticosteroid free ointment for treatment of eczema

Phase 3
Recruiting
Conditions
eczema.
Other atopic dermatitis
L20.89
Registration Number
IRCT20140624018210N10
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
75
Inclusion Criteria

Only patients with active eczema lesions are included in this study.

Exclusion Criteria

Patients with very large (severe) lesions
Patients with a history of skin diseases other than eczema

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1) itching 2) redness 3) burning 4) inflammation 5) wound healing. Timepoint: End of the treatment period. Method of measurement: Clinical examination.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath